Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression
- PMID: 25871467
- DOI: 10.1097/PAS.0000000000000413
Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression
Abstract
Salivary duct carcinoma (SDC) is a prototypic aggressive salivary gland carcinoma. Our aim is to determine the prevalence of histologic variants (micropapillary, basal-like) and androgen receptor (AR) expression in a large multi-institutional series of SDC. AR status was determined by immunohistochemistry (IHC). Most SDCs were characterized by an apocrine phenotype and AR expression. Cases with a nonapocrine phenotype and AR-negative status were studied by additional IHC and fluorescence in situ hybridization for ETV6 or MYB/NFIB. The diagnosis of SDC was confirmed in 187 of 199 (94%) cases. Variant morphologies were identified in 12 cases: micropapillary (n=6), sarcomatoid (n=3), mucinous (n=2), and basal-like (n=1). AR IHC was performed in 183 cases, of which 179 (97.8%) showed AR expression. On the basis of morphologic appearance and results of additional studies, 12 cases were reclassified as squamous cell carcinoma (SCC) (n=4), epithelial-myoepithelial carcinoma with high-grade transformation (HGT) (n=2), myoepithelial carcinoma (n=2), mammary analogue secretory carcinoma, high grade (ETV6 translocated; n=1), adenoid cystic carcinoma with HGT (n=1), acinic cell carcinoma with HGT (n=1), and adenosquamous carcinoma (n=1). AR-negative SDC is extremely rare, and the majority of such cases are more accurately classified as other entities. HGTs of other salivary carcinomas and squamous cell carcinoma are the most common mimics of SDC. SDCs with variant morphologies still show at least a minor component of conventional apocrine appearance. Thus, apocrine morphology defines SDC.
Similar articles
-
Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma.Mod Pathol. 1998 Nov;11(11):1033-8. Mod Pathol. 1998. PMID: 9831198
-
Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.Hum Pathol. 2013 Nov;44(11):2501-8. doi: 10.1016/j.humpath.2013.06.010. Epub 2013 Sep 10. Hum Pathol. 2013. PMID: 24029710
-
Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.Head Neck Pathol. 2017 Sep;11(3):288-294. doi: 10.1007/s12105-017-0798-x. Epub 2017 Mar 20. Head Neck Pathol. 2017. PMID: 28321773 Free PMC article. Review.
-
Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.Am J Surg Pathol. 2007 Nov;31(11):1645-52. doi: 10.1097/PAS.0b013e3180caa099. Am J Surg Pathol. 2007. PMID: 18059220
-
The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.Am J Surg Pathol. 2018 Feb;42(2):e11-e27. doi: 10.1097/PAS.0000000000000980. Am J Surg Pathol. 2018. PMID: 29076877 Review.
Cited by
-
An Unusual Case of Metachronous Tumors of Prostate and Parotid Gland: A Diagnostic Dilemma.Cureus. 2023 Nov 7;15(11):e48477. doi: 10.7759/cureus.48477. eCollection 2023 Nov. Cureus. 2023. PMID: 38074059 Free PMC article.
-
NKX3.1 Expression and Molecular Characterization of Secretory Myoepithelial Carcinoma (SMCA): Advancing the Case for a Salivary Mucous Acinar Phenotype.Head Neck Pathol. 2023 Jun;17(2):467-478. doi: 10.1007/s12105-023-01524-2. Epub 2023 Feb 6. Head Neck Pathol. 2023. PMID: 36746884 Free PMC article.
-
Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.Hum Pathol. 2019 Nov;93:30-36. doi: 10.1016/j.humpath.2019.08.007. Epub 2019 Aug 17. Hum Pathol. 2019. PMID: 31430492 Free PMC article.
-
SOX10 Is a Sensitive Marker for Breast and Salivary Gland Adenoid Cystic Carcinoma: Immunohistochemical Characterization of Adenoid Cystic Carcinomas.Breast Cancer (Auckl). 2019 May 3;13:1178223419842185. doi: 10.1177/1178223419842185. eCollection 2019. Breast Cancer (Auckl). 2019. PMID: 31105427 Free PMC article.
-
Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report.Front Oncol. 2020 Oct 2;10:559057. doi: 10.3389/fonc.2020.559057. eCollection 2020. Front Oncol. 2020. PMID: 33123470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials